Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.8480
+0.0237 (2.88%)
At close: Jun 6, 2025, 4:00 PM
0.8600
+0.0120 (1.42%)
After-hours: Jun 6, 2025, 7:33 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Site-specific and Novel-format Antibody Drug Conjugates
153.73M
Log In
Log In
Log In
Log In
Upgrade
Site-specific and Novel-format Antibody Drug Conjugates Growth
126.84%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
153.73M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
126.84%
Log In
Log In
Log In
Log In
Upgrade